IN2012DN02245A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02245A
IN2012DN02245A IN2245DEN2012A IN2012DN02245A IN 2012DN02245 A IN2012DN02245 A IN 2012DN02245A IN 2245DEN2012 A IN2245DEN2012 A IN 2245DEN2012A IN 2012DN02245 A IN2012DN02245 A IN 2012DN02245A
Authority
IN
India
Prior art keywords
nutritional compositions
vitamin
nutritional
osteopontin
manganese
Prior art date
Application number
Other languages
English (en)
Inventor
Douglas Richard Bolster
Zamzam Kabiry Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN02245A publication Critical patent/IN2012DN02245A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
IN2245DEN2012 2009-09-14 2010-09-01 IN2012DN02245A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24208709P 2009-09-14 2009-09-14
US25084709P 2009-10-12 2009-10-12
US34794510P 2010-05-25 2010-05-25
US37184610P 2010-08-09 2010-08-09
PCT/US2010/047468 WO2011031602A1 (fr) 2009-09-14 2010-09-01 Compositions nutritionnelles destinees a moduler l'inflammation, contenant de la vitamine k2 exogene

Publications (1)

Publication Number Publication Date
IN2012DN02245A true IN2012DN02245A (fr) 2015-05-22

Family

ID=43098924

Family Applications (2)

Application Number Title Priority Date Filing Date
IN2184DEN2012 IN2012DN02184A (fr) 2009-09-14 2010-09-01
IN2245DEN2012 IN2012DN02245A (fr) 2009-09-14 2010-09-01

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2184DEN2012 IN2012DN02184A (fr) 2009-09-14 2010-09-01

Country Status (16)

Country Link
US (5) US20120208893A1 (fr)
EP (2) EP2477510B1 (fr)
JP (3) JP2013504572A (fr)
CN (2) CN102781258A (fr)
AU (2) AU2010292439A1 (fr)
BR (1) BR112012005783A2 (fr)
CA (2) CA2773940A1 (fr)
DK (1) DK2477510T3 (fr)
ES (1) ES2669004T3 (fr)
IN (2) IN2012DN02184A (fr)
MX (2) MX2012003080A (fr)
RU (2) RU2012114832A (fr)
SG (2) SG179065A1 (fr)
TR (1) TR201808128T4 (fr)
WO (2) WO2011031601A2 (fr)
ZA (2) ZA201202711B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130028864A1 (en) * 1998-04-08 2013-01-31 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating brain inflammation
EP2477510B1 (fr) * 2009-09-14 2018-03-07 Nestec S.A. Compositions nutritionnelles destinees a moduler l'inflammation, contenant de la vitamine k2 exogene
EP2699111A1 (fr) * 2011-04-18 2014-02-26 Nestec S.A. Compositions nutritionnelles comprenant de l'alpha-hydroxyisocaproïque
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CN102772401A (zh) * 2011-10-02 2012-11-14 南京大学 鼠尾草酚的抗骨质疏松新用途
WO2013144268A1 (fr) * 2012-03-29 2013-10-03 Nestec S.A. Nutrition et exercice physique contre la malnutrition associée à la prise de médicaments chez les enfants
WO2013144267A2 (fr) * 2012-03-29 2013-10-03 Nestec S.A. Amélioration de la santé musculosquelettique par nutrition et exercice
BR112015001884B1 (pt) * 2012-07-31 2020-12-01 Société des Produits Nestlé S.A. composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida
WO2014040122A1 (fr) 2012-09-11 2014-03-20 Dakota Star Capital Llc Fer contenant un complément nutritionnel
CN103142640A (zh) * 2013-04-01 2013-06-12 李拖平 含有维生素k2的具有预防与治疗骨质疏松症的保健品
CN108369223B (zh) * 2015-12-30 2021-07-06 雀巢产品有限公司 用于测定去脂体重的方法
CN105815791B (zh) * 2016-03-24 2018-12-18 刘超 一种具有增肌功能并消除不良反应的组合物
AU2017274438A1 (en) * 2016-06-02 2018-12-13 Ana Pharmaceuticals, Inc. Methods and compositions for treatment of hypercalciuria and nephrolithiasis
WO2020186161A2 (fr) * 2019-03-13 2020-09-17 The Regents Of The University Of California Compositions et procédés de régulation de la croissance utérine et placentaire
CN110122866A (zh) * 2019-05-31 2019-08-16 广东双骏生物科技有限公司 一种慢性肾脏病血管钙化的特殊医学用途食品及制备方法
TR202002698A2 (tr) * 2020-02-21 2021-09-21 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Kemoterapi̇ ve/veya radyoterapi̇ alan ve/veya cerrahi̇ öncesi̇ ve
WO2023275183A1 (fr) 2021-06-29 2023-01-05 Kappa Bioscience As Composition comprenant de la vitamine k, de la vitamine d, de la xanthophylle et de l'epa et/ou du dha
CN115989871A (zh) * 2021-10-20 2023-04-21 安琪纽特股份有限公司 一种促进生长发育的组合物及其制备方法和应用
CN115590198B (zh) * 2022-09-26 2024-06-18 黑龙江飞鹤乳业有限公司 核苷酸的用途、营养组合物、食品及其用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US250847A (en) 1881-12-13 Vehicle-top
US242087A (en) 1881-05-24 Machine for making laps on belting
US347945A (en) 1886-08-24 vavtu
US371846A (en) 1887-10-18 Tennis-racket
JPH07119191B2 (ja) * 1990-08-16 1995-12-20 株式会社日本触媒 メナジオン亜硫酸水素塩の安定化方法及びメナジオン亜硫酸水素塩組成物
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
EP0689835A3 (fr) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition comprenant un mélange d'acides aminés et au moins un acide gras du type N-3
WO1997039746A1 (fr) * 1996-04-22 1997-10-30 Advanced Polymer Systems, Inc. Procede et composition servant a traiter des maladies de la peau au moyen de vitamine k
JP3459932B2 (ja) * 1996-07-23 2003-10-27 株式会社ホーネンコーポレーション 抗骨粗鬆症組成物
DE60036750T2 (de) * 1999-05-18 2008-08-28 Nipro Corp. Verfahren zur Abschätzung der Sensitivität für Osteoporose-Medikamente
DK1153548T3 (da) * 2000-05-12 2007-09-10 Nattopharma Asa Levnedsmiddelprodukt, der indeholder vitamin k2
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
GB2370503A (en) * 2000-12-27 2002-07-03 Novartis Nutrition Ag Compositions comprising vitamin K
JP4131443B2 (ja) * 2001-08-27 2008-08-13 株式会社J−オイルミルズ 抗骨粗鬆症組成物
JP2004155658A (ja) * 2002-11-01 2004-06-03 Kyowa Hakko Kogyo Co Ltd TNF−α産生抑制剤
US20050123603A1 (en) * 2003-09-26 2005-06-09 Natural Asa Natural menaquinone 7 compositions
WO2005107731A1 (fr) * 2004-05-12 2005-11-17 Eisai R & D Management Co., Ltd. Remèdes contenant de la vitamine k2 comme ingrédient actif
CA2568775C (fr) * 2004-06-04 2012-09-11 David Kannar Edulcorant naturel
US20060223730A1 (en) * 2005-04-04 2006-10-05 Hl Distribution Company Calcium supplements
JP2006325487A (ja) * 2005-05-26 2006-12-07 Pola Chem Ind Inc 栄養補給用固形食品
EP1889613A4 (fr) * 2005-05-27 2010-11-24 Shionogi & Co Composition pharmaceutique comprenant de la vitamine k
BE1016895A6 (fr) * 2005-12-16 2007-09-04 Psaltopoulos Emmanuel MOLECULE INCORPORANT LE CALCIUM (CA), LA VITAMINE "D" ET LA VITAMINE "K" POUR LA PREVENTION ET LE TRAITEMENT DE l'OSTEOPOROSE AINSI QUE POUR LA PREVENTION DE LA CALCIFICATION VASCULAIRE ET POUR LA PREVENTION DE LA CALCIFICATION DU CARTILAGE DES ARTICULATIONS.
CA2641315A1 (fr) * 2006-02-06 2007-08-16 Tethys Bioscience, Inc. Marqueurs associes a l'osteoporose et leurs methodes d'utilisation
US9011930B2 (en) * 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof
CA2657748C (fr) * 2006-07-14 2014-10-21 Nattopharma Asa Produits pharmaceutiques et nutritceutiques comprenant de la vitamine k2
FR2906816B1 (fr) * 2006-10-04 2012-04-06 Gervais Danone Sa Variants de bacteries lactiques utiles pour produire la vitamine k2 et leurs applications a la preparation de produits alimentaires
US20080220094A1 (en) * 2006-11-01 2008-09-11 Wyeth Compositions and methods for the treatment and/or prevention of osteoporosis
WO2009063485A2 (fr) * 2007-07-24 2009-05-22 Viridis Biopharma Pvt Ltd. Traitement de conditions et troubles de maladie humaine mettant en œuvre des analogues de la vitamine k et leurs dérivés
NL1034964C2 (nl) * 2008-01-28 2009-07-30 Friesland Brands Bv Werkwijze en composities voor de behandeling van botaandoeningen.
WO2009105234A2 (fr) * 2008-02-19 2009-08-27 Combinatorx, Incorporated Procédés et compositions pour le traitement de troubles associés à des défauts du gène ou de la protéine du régulateur de la conductance transmembranaire d'une fibrose kystique
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
EP2477510B1 (fr) * 2009-09-14 2018-03-07 Nestec S.A. Compositions nutritionnelles destinees a moduler l'inflammation, contenant de la vitamine k2 exogene

Also Published As

Publication number Publication date
RU2012114786A (ru) 2013-10-27
WO2011031601A3 (fr) 2011-06-03
US20160220511A1 (en) 2016-08-04
JP2013504571A (ja) 2013-02-07
US20170105948A1 (en) 2017-04-20
ZA201202712B (en) 2014-10-29
CA2773940A1 (fr) 2011-03-17
CN102596190A (zh) 2012-07-18
JP2016041705A (ja) 2016-03-31
JP2013504572A (ja) 2013-02-07
WO2011031601A2 (fr) 2011-03-17
US20130052274A1 (en) 2013-02-28
MX2012003081A (es) 2012-04-19
US9687456B2 (en) 2017-06-27
AU2010292440A1 (en) 2012-04-12
CA2773957C (fr) 2018-01-09
BR112012005783A2 (pt) 2017-05-30
TR201808128T4 (tr) 2018-07-23
RU2012114832A (ru) 2013-10-27
EP2477510A1 (fr) 2012-07-25
SG179065A1 (en) 2012-04-27
SG179064A1 (en) 2012-04-27
MX2012003080A (es) 2012-04-19
WO2011031602A1 (fr) 2011-03-17
US20120208893A1 (en) 2012-08-16
ES2669004T3 (es) 2018-05-23
EP2477618A2 (fr) 2012-07-25
IN2012DN02184A (fr) 2015-05-22
CA2773957A1 (fr) 2011-03-17
AU2010292440B2 (en) 2015-06-18
AU2010292439A1 (en) 2012-04-12
US20130323361A1 (en) 2013-12-05
CN102781258A (zh) 2012-11-14
EP2477510B1 (fr) 2018-03-07
ZA201202711B (en) 2014-10-29
DK2477510T3 (en) 2018-05-28

Similar Documents

Publication Publication Date Title
IN2012DN02184A (fr)
IN2012DN00548A (fr)
IN2012DN00746A (fr)
EP2620455A4 (fr) Procédé de production de polybutadiène à terminaison acrylique modifiée ou de polybutadiène hydrogéné à terminaison acrylique modifiée, et composition contenant ledit polybutadiène
PL2374908T3 (pl) Przyjazny dla środowiska stop mosiądzu manganowego oraz sposób jego wytwarzania
WO2010077740A3 (fr) Nouveaux composés antiviraux, compositions et procédés d'utilisation
TW200727907A (en) Meatllic taste masking composition
ZA201102754B (en) Lipochito-oligosaccharides stimulating arbuscular mycorrhizal symbiosis
EP2322139A3 (fr) Composition comprenant un polyol et un polymère modifié polaire à forte teneur en carbone soluble dans l'huile
EP2322248A3 (fr) Composition comprenant un polyol et un polymère modifié polaire soluble dans l'huile
PL2274373T3 (pl) Mieszaniny zmiatające tlen
EP2316413A3 (fr) Compositions comprenant un inhibiteur de NFkB et un promoteur du collagène non rétinoïde
WO2011023560A3 (fr) Compositions inhibant les odeurs
HK1222096A1 (zh) 含有安石榴苷的營養組合物
WO2011160053A3 (fr) Polymères stables à la fusion
EP2722045A3 (fr) Compositions pour traiter les nausées et vomissements à médiation centrale
EP2446985A4 (fr) Mélange pulvérulent à base de fer pour métallurgie des poudres
WO2011019641A3 (fr) Compositions nutritionnelles comprenant des nucléotides exogènes
MX2011013790A (es) Derivados de flavina.
IL212713A0 (en) Kits and compositions comprising methotrexate combinations and uses thereof.
WO2011029102A3 (fr) Cellules cd117+ et leurs utilisations
GB2495687A (en) Nutritional compositions comprising chitin microparticles
WO2012033893A3 (fr) Hyperhalogènes et compositions hautement électronégatives
MX2015001982A (es) Proceso de produccion de resina de colofonia, producto obtenido por dicho proceso y su uso.
WO2010121226A3 (fr) Agents anticancéreux